FUJIFILM Irvine Scientific has added the Life Whisperer Genetics module to its Life Whisperer software package (launched in 2021), enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilisation (IVF).
Life Whisperer Genetics used in conjunction with Life Whisperer Viability uniquely aids in the clinical selection of blastocysts that may have a greater likelihood of being euploid and resulting in pregnancy using a single platform. Since 2021, FUJIFILM Irvine Scientific has been the the sole worldwide distributor of Life Whisperer, the fertility arm of Presagen, a leader in AI healthcare.
“At Presagen, we continue with our goal to improving health through the implementation of Life Whisperer Genetics artificial intelligence,” said Dr Michelle Perugini, Chief Executive Officer and Co-founder at Presagen. “The Life Whisperer platform was developed with a network of IVF clinics around the world to provide a single suite of AI-based technologies for a non-invasive, objective option along with a seamless workflow solution to aid clinicians in the IVF process.”
The Life Whisperer platform’s AI-based approach analyses day-five blastocysts’ morphological features that correlate with increased likelihood of clinical pregnancy to produce a confidence score from 0 to 10 across both Life Whisperer Viability and Life Whisperer Genetics modules. Research has shown Life Whisperer Viability may improve selection of viable embryos by up to 25% vs embryologist assessment alone. In a simulated cohort study, Life Whisperer Genetics identified the top-ranked embryo as euploid in 82.4% of cohorts.
By using the non-invasive single platform, the embryologist or clinician has an objective assessment and consistent grading aid to clinical decision-making and helping patients build families.
The Life Whisper platform is cloud-based and compatible with standard optical microscope and image-capture software to streamline integration into existing IVF workflows.
Steven Geimer, executive director of Medical Business Unit at FUJIFILM Irvine Scientific, said: “The Life Whisperer platform further solidifies our commitment to introduce new solutions to support embryologists and clinicians in increasing a patient’s pregnancy potential. AI-based analysis is one example of how we continue to push for innovative, non-invasive solutions to provide clinicians with objective decision-making tools in IVF procedures and clinic workflows, thereby assisting in achieving the desired results.”